|
Mar 7, 2008 VSHD launches “Misoprostol Day” in Ethiopia; Prime
Minister’s Wife Attends More than 800 female delegates attended Misoprostol Day, an innovative and successful information, education and
communication campaign, at the annual Women’s Association meeting in
the remote region of Tigray.
Ethiopia is
the first country in the world to engage women’s groups on a large scale for
share the knowledge of postpartum hemorrhage and misoprostol.
Feb 8, 2008
Nepal registers second misoprostol product for obstetric purposes in decisive step towards greater availability
The Nepali Department of Drug Administration has officially announced it has approved the registration of a second misoprostol product for obstetric
purposes. Nov 20, 2007 Misoprostol's importance to mitigate maternal mortality due to postpartum hemorrhage highlighted at the Annual Meeting of
Ob/Gyns in Nigeria VSHD sponsored a misoprostol workshop at the widely attended
41st Scientific Conference
and Annual General Meeting of the Society of Gynecology and
Obstetrics of Nigeria (SOGON) in Benin City, Edo State, Nigeria, November 14-17, 2007.
The theme of
the Conference was “Intersectoral Collaboration for Promoting Maternal and
Neonatal Health”, with the relevant sub-theme of “Postpartum Hemorrhage" (PPH).
At the close of the conference several key resolutions were
made; resolution number 2 highlighted the importance of misoprostol to mitigate maternal mortality due to
PPH. Sep 27, 2007 Tanzania registers misoprostol for postpartum hemorrhage: Second country in Africa to approve this life-saving drug The Tanzanian Food and Drug Authority officially announced today it has approved the registration of misoprostol for controlling postpartum hemorrhage
(PPH), the life-threatening bleeding after childbirth attributed to the loss of approximately
5,250 mother's lives annually in Tanzania. Jul 19, 2007 Frontline Health Extension Workers trained in misoprostol use throughout rural
Ethiopia As of May 2007,
128 health extension workers representing 97 rural health posts throughout four regions of the
country have been trained in
the administration of oral misoprostol tablets to women during the third stage
of labor to prevent PPH in the Ministry of Health's
project titled, “Misoprostol for the prevention
of PPH at the community level.” Jun 18, 2007 Nearly 250 health care providers attended trainings on the use of misoprostol for
PPH in three regions of the country. In May 2007, Venture Strategies, in collaboration with local partners, completed training workshops to
242 healthcare professionals on
reducing maternal mortality and morbidity through Active Management of
Third
Stage of Labor (AMTSL) and the judicious use of misoprostol for the
treatment
of postpartum hemorrhage (PPH) in three key regions of the country:
Lagos, Abuja, and Port Harcourt. Mar 9, 2007 The training series, "Community level prevention of postpartum hemorrhage by introducing
misoprostol" initiated in Ethiopia Venture Strategies, in conjunction with the Ethiopian Ministry of Health and local collaborating
agencies, has initiated trainings at the community level in Ethiopia that underscore the
importance of misoprostol as a key strategy to control
postpartum hemorrhage - the primary cause of maternal death worldwide. Mar 9, 2007 AMTSL trainings highlighting "judicious use" of misoprostol launched in Nigeria Venture Strategies, in conjunction with local collaborating
agencies, has initiated trainings for health care professionals in Nigeria underscoring the
importance of misoprostol as a key strategy to control
postpartum hemorrhage - the primary cause of maternal death worldwide. Mar 4, 2007 Study highlights role of the private sector and STI prevalence in
Uganda A recently completed baseline survey provides a healthcare
utilization profile of southwestern Uganda as well as
baseline indicators and benchmarks for the Ugandan
output-based aid
program. Oct 10, 2006 National Public Radio (NPR) features study showing misoprostol is effective at preventing excessive bleeding after
childbirth A
new study led by Dr. Richard Derman finds that the
low-cost drug misoprostol can reduce life-threatening bleeding after childbirth by up to 47 percent. NPR highlights that misoprostol can be used to prevent the leading cause of maternal death in the most remote settings in developing countries where women often deliver at
home. Listen to the story here. |
|
